HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frank Edelmann Selected Research

ACT protocol

8/2021Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frank Edelmann Research Topics

Disease

76Heart Failure
04/2024 - 09/2008
14Atrial Fibrillation
02/2024 - 12/2010
12Fibrosis (Cirrhosis)
03/2024 - 10/2013
9Diastolic Heart Failure
07/2023 - 08/2010
7Hypertension (High Blood Pressure)
12/2022 - 01/2015
6Cardiovascular Diseases (Cardiovascular Disease)
07/2023 - 12/2014
5Inflammation (Inflammations)
11/2023 - 02/2015
4Necrosis
11/2023 - 02/2017
4Disease Progression
02/2023 - 12/2015
3Heart Diseases (Heart Disease)
11/2023 - 10/2018
3Acute Coronary Syndrome
08/2021 - 05/2013
3Stroke (Strokes)
01/2015 - 08/2012
2Left Ventricular Dysfunction
04/2024 - 01/2018
2Dyslipidemias (Dyslipidemia)
11/2023 - 07/2023
2Non-alcoholic Fatty Liver Disease
11/2023 - 07/2023
2Type 2 Diabetes Mellitus (MODY)
11/2023 - 01/2023
2Hypertrophy
11/2023 - 10/2018
2Body Weight (Weight, Body)
10/2023 - 10/2022
2Iron Deficiencies
01/2023 - 01/2021
2Chronic Renal Insufficiency
01/2023 - 11/2015
2Myocardial Infarction
12/2022 - 05/2013
2Coronary Artery Disease (Coronary Atherosclerosis)
08/2022 - 01/2020
2Fatigue
12/2021 - 04/2019
2Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2020 - 10/2019
2Systolic Heart Failure
06/2016 - 12/2010
2Brain Ischemia (Cerebral Ischemia)
12/2013 - 01/2012
1Heart Valve Diseases (Valvular Heart Disease)
12/2023
1Chronic Obstructive Pulmonary Disease (COPD)
12/2023
1Morbid Obesity
10/2023
1Dyspnea (Shortness of Breath)
05/2023
1Diabetes Mellitus
12/2022
1Sleep Apnea Syndromes (Sleep Apnea)
08/2022
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2022
1Hypotension (Low Blood Pressure)
01/2022
1Coronary Disease (Coronary Heart Disease)
11/2021

Drug/Important Bio-Agent (IBA)

23Biomarkers (Surrogate Marker)IBA
11/2023 - 12/2010
21Spironolactone (Aldactone)FDA LinkGeneric
03/2024 - 08/2010
14pro-brain natriuretic peptide (1-76)IBA
03/2024 - 01/2012
9Natriuretic PeptidesIBA
11/2023 - 01/2012
9AldosteroneIBA
07/2023 - 08/2010
7Brain Natriuretic Peptide (Natrecor)FDA Link
01/2023 - 01/2019
7CollagenIBA
12/2022 - 01/2014
6Galectin 3 (LGALS3)IBA
01/2022 - 10/2013
5Collagen Type I (Type I Collagen)IBA
01/2023 - 01/2018
5sacubitril and valsartan sodium hydrate drug combinationIBA
12/2022 - 01/2020
5Bisoprolol (Concor)FDA LinkGeneric
02/2016 - 09/2008
4Mineralocorticoid Receptor AntagonistsIBA
02/2024 - 01/2021
4Oxygen (Dioxygen)IBA
12/2023 - 01/2020
4Proteins (Proteins, Gene)FDA Link
02/2023 - 01/2018
4Procollagen Type IIBA
01/2023 - 01/2018
4Carvedilol (Coreg)FDA LinkGeneric
02/2016 - 09/2008
3DiureticsIBA
03/2024 - 02/2009
3vericiguatIBA
03/2024 - 01/2021
34-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
12/2021 - 06/2014
3Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
12/2021 - 08/2010
2CytokinesIBA
11/2023 - 11/2015
2mirabegronIBA
11/2023 - 10/2018
2procollagen type I carboxy terminal peptide (PICP)IBA
01/2023 - 01/2022
2IronIBA
01/2023 - 01/2021
2CreatinineIBA
01/2022 - 01/2021
2AdrenomedullinIBA
10/2021 - 12/2015
2EnalaprilFDA LinkGeneric
01/2021 - 01/2020
2LipidsIBA
01/2021 - 01/2021
2proAVP hormoneIBA
01/2019 - 02/2017
2Growth Differentiation Factor 15IBA
08/2012 - 12/2010
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2011 - 02/2009
1Insulin-Like Growth Factor Binding Protein 2IBA
03/2024
1Galectin 4 (LGALS4)IBA
11/2023
1Plasminogen Activator Inhibitor 1IBA
11/2023
1Matrix Metalloproteinase 7 (Matrilysin)IBA
11/2023
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2023
1peptidoglycan recognition proteinIBA
11/2023
1Trans Fatty AcidsIBA
11/2023
1Lipoproteins (Lipoprotein)IBA
11/2023
1Clostridium perfringens epsilon-toxinIBA
10/2023
1palmitoleic acidIBA
07/2023
1Monounsaturated Fatty AcidsIBA
07/2023
1perlecanIBA
02/2023
1Platelet-Derived Growth FactorIBA
02/2023
1Junctional Adhesion Molecule AIBA
02/2023
1finerenoneIBA
01/2023
1Glucose (Dextrose)FDA LinkGeneric
12/2022
1Urea (Carbamide)FDA LinkGeneric
12/2022
1ThiazidesIBA
12/2022
1PotassiumIBA
12/2022
1omega-Chloroacetophenone (Mace)IBA
12/2022
1Fatty Acids (Saturated Fatty Acids)IBA
09/2022
1Triglycerides (Triacylglycerol)IBA
07/2022
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
03/2022
1procollagen Type III-N-terminal peptide (PIIP)IBA
01/2022
1Collagen Type III (Type III Collagen)IBA
01/2022
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
12/2021

Therapy/Procedure

20Therapeutics
04/2024 - 02/2009
2Heart-Assist Devices
09/2023 - 01/2019
2Resistance Training
01/2023 - 09/2014
1Transplantation
04/2024
1Bariatric Surgery
10/2023
1Activities of Daily Living (ADL)
05/2023
1Caloric Restriction
01/2023
1Exoskeleton Device
01/2022